Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camillo Porta

Showing results (61-70 of 426) with videos related to

Pageof 43
Sort By:
World Journal of Nephrology|February 4, 2022
Renal cell carcinoma and viral infections: A dangerous relationship?Melissa Bersanelli, Chiara Casartelli, Sebastiano Buti, et al.
Oncology Letters|November 4, 2017
Renin angiotensin system deregulation as renal cancer risk factorPaweł Sobczuk, Cezary Szczylik, Camillo Porta, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 6, 2015
Onco-nephrology: a decalogueLaura Cosmai, Camillo Porta, Maurizio Gallieni, et al.
International Journal of Oncology|April 2, 2016
Hormone signaling pathways as treatment targets in renal cell cancer (Review)Anna M Czarnecka, Magdalena Niedzwiedzka, Camillo Porta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
Harmonization of Renal Function Assessment Is Needed Throughout the Whole Process of Anticancer Drug DevelopmentCamillo Porta, Laura Cosmai, Maurizio Gallieni, et al.
Translational Oncology|June 18, 2021
Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related researchFrancesca Negri, Gabriele Missale, Anna Degli Antoni, et al.
BJU International|November 17, 2010
A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment optionsJoaquim Bellmunt, Tim Eisen, Cezary Szczylik, et al.
Expert Opinion on Biological Therapy|December 15, 2016
Immuno-oncology for renal cell carcinoma treatment: future perspectives for combinations and sequences with molecularly targeted agentsCamillo Porta, Ilaria Toscani, Anna M Czarnecka, et al.
Cancer Treatment Reviews|October 13, 2009
Treating the individual: The need for a patient-focused approach to the management of renal cell carcinomaCamillo Porta, Joaquim Bellmunt, Tim Eisen, et al.
Clinical Genitourinary Cancer|January 13, 2024
Management of Adverse Reactions Related to Lenvatinib Plus Pembrolizumab Treatment Among Patients With Renal Cell CarcinomaViktor Grünwald, James Larkin, Javier Puente, et al.
Pageof 43

Showing results (61-70 of 426) with videos related to

Sort By:
Pageof 43
World Journal of Nephrology|February 4, 2022
Renal cell carcinoma and viral infections: A dangerous relationship?Melissa Bersanelli, Chiara Casartelli, Sebastiano Buti, et al.
Oncology Letters|November 4, 2017
Renin angiotensin system deregulation as renal cancer risk factorPaweł Sobczuk, Cezary Szczylik, Camillo Porta, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 6, 2015
Onco-nephrology: a decalogueLaura Cosmai, Camillo Porta, Maurizio Gallieni, et al.
International Journal of Oncology|April 2, 2016
Hormone signaling pathways as treatment targets in renal cell cancer (Review)Anna M Czarnecka, Magdalena Niedzwiedzka, Camillo Porta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
Harmonization of Renal Function Assessment Is Needed Throughout the Whole Process of Anticancer Drug DevelopmentCamillo Porta, Laura Cosmai, Maurizio Gallieni, et al.
Translational Oncology|June 18, 2021
Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related researchFrancesca Negri, Gabriele Missale, Anna Degli Antoni, et al.
BJU International|November 17, 2010
A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment optionsJoaquim Bellmunt, Tim Eisen, Cezary Szczylik, et al.
Expert Opinion on Biological Therapy|December 15, 2016
Immuno-oncology for renal cell carcinoma treatment: future perspectives for combinations and sequences with molecularly targeted agentsCamillo Porta, Ilaria Toscani, Anna M Czarnecka, et al.
Cancer Treatment Reviews|October 13, 2009
Treating the individual: The need for a patient-focused approach to the management of renal cell carcinomaCamillo Porta, Joaquim Bellmunt, Tim Eisen, et al.
Clinical Genitourinary Cancer|January 13, 2024
Management of Adverse Reactions Related to Lenvatinib Plus Pembrolizumab Treatment Among Patients With Renal Cell CarcinomaViktor Grünwald, James Larkin, Javier Puente, et al.
Pageof 43